- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on NASH (Nonalcoholic Steatohepatitis) in United Kingdom
Total 416 results
-
SanofiTerminatedFatty LiverUnited States, France, Brazil, Poland, Romania, Germany, Portugal, Spain, Switzerland, Malaysia, Philippines, Taiwan, Belgium, Mexico, Argentina, Croatia, Hungary, Italy, Colombia, Chile, United Kingdom, Puerto Rico, Australia, China
-
University of California, DavisCompletedMetabolic Syndrome | Nonalcoholic SteatohepatitisUnited States
-
Bristol-Myers SquibbCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Liver Fibrosis | Hepatic CirrhosisUnited States
-
William Beaumont HospitalsTerminatedFibrosis, Liver | Cirrhosis, Liver | Steatohepatitis, Nonalcoholic | Fatty Liver DiseaseUnited States
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Israel, Taiwan, Canada, Australia, Poland
-
MedImmune LLCCompletedNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)United States, Puerto Rico
-
AstraZenecaParexelCompletedNon-alcoholic SteatohepatitisUnited Kingdom
-
Methodist Health SystemWithdrawnNon-alcoholic Steatohepatitis (NASH)United States
-
University of California, DavisNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingNon-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)United States
-
University of BathAbertay UniversityCompletedNon-alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisUnited Kingdom
-
Dartmouth-Hitchcock Medical CenterCompletedHepatic Steatosis | Nonalcoholic Fatty Liver Disease | SteatohepatitisUnited States
-
Jeffrey BrowningNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedHealthy | NASH (Non-Alcoholic Steatohepatitis) | NAFLD (Non-Alcoholic Fatty Liver Disease)United States
-
PfizerCompletedNon-alcoholic Fatty Liver Disease | Non-alcoholic SteatohepatitisUnited States
-
Grand Valley State UniversityEnrolling by invitationMetabolic Associated-dysfunction Steatotic Liver Disease (MASLD) | Metabolic Associated-dysfunction Steatohepatitis (MASH)United States
-
University of Missouri-ColumbiaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); American...CompletedObesity, Morbid | Bariatric Surgery Candidate | Nonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States
-
89bio, Inc.ProSciento, Inc.Completed
-
Sagimet Biosciences Inc.CompletedNonalcoholic Fatty Liver DiseaseUnited States, Canada, Puerto Rico, Poland
-
Brigham and Women's HospitalBoston Scientific Corporation; American Society for Gastrointestinal EndoscopyRecruitingObesity | Non-alcoholic Fatty Liver Disease (NAFLD) | Liver Function | Non-alcoholic Steatohepatitis (NASH) | Liver Fibroses | Endoscopic Ultrasound | Endoscopic Sleeve GastroplastyUnited States
-
National Cancer Institute (NCI)RecruitingHepatocellular Carcinoma | Nonalcoholic SteatohepatitisUnited States
-
Yaqrit LtdAssistance Publique - Hôpitaux de Paris; IRCCS Azienda Ospedaliero-Universitaria... and other collaboratorsWithdrawnNon-Alcoholic SteatohepatitisFrance, Italy, Portugal, Spain, Switzerland, United Kingdom
-
University of Kansas Medical CenterGilead SciencesRecruiting
-
Hepion Pharmaceuticals, Inc.Active, not recruitingNASH With FibrosisUnited Kingdom
-
Meridian Bioscience, Inc.CompletedNon-Alcoholic SteatohepatitisUnited States, France, Belgium, United Kingdom
-
University of PittsburghTerminatedNonalcoholic Steatohepatitis | Post Liver Transplantation Weight Gain | Post Liver Transplantation ObesityUnited States
-
Medical College of WisconsinENDRA Life Sciences, Inc.RecruitingFatty Liver | NAFLD | Non-Alcoholic Fatty Liver Disease | Non-alcoholic Steatohepatitis | Non-alcoholic Fatty Liver | NASH | Fatty Liver DiseaseUnited States
-
University of PittsburghCompletedSteatohepatitis, Nonalcoholic | Alcoholic Liver Disease | Non-Alcoholic Fatty Liver Disease | SteatohepatitisUnited States
-
Ali AminianNot yet recruitingObesity | Liver Fibrosis | Non-Alcoholic Fatty Liver Disease | Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) | Metabolic Dysfunction-Associated Steatohepatitis (MASH)United States, Sweden, Ireland, Finland, United Kingdom, Spain, Switzerland, Brazil, Canada, Italy, Kuwait, India, Mexico
-
University of FloridaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingNonalcoholic Steatohepatitis | Type 2 Diabetes Mellitus (T2DM)United States
-
HighTide Biopharma Pty LtdCompletedDigestive System Diseases | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Type 2 Diabetes Mellitus (T2DM) | Fatty Liver, NonalcoholicUnited States
-
Michael Ohliger, MD PhDNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingNAFLD | Non-Alcoholic Fatty Liver Disease | NASH | Non Alcoholic Fatty Liver | Non Alcoholic SteatohepatitisUnited States
-
University of MichiganCompletedNAFLD | Nonalcoholic Steatohepatitis | Familial Partial LipodystrophyUnited States
-
Imperial College LondonActive, not recruiting
-
University of California, San FranciscoUniversity of Colorado, Denver; The Methodist Hospital Research InstituteTerminatedEnd Stage Liver Disease | Chronic Kidney Diseases | Hepatitis B | Hepatocellular Carcinoma | Cirrhosis | Acute Kidney Injury | NASH - Nonalcoholic Steatohepatitis | Liver Transplant; Complications | Alcoholic Cirrhosis | Hepatitis cUnited States
-
Enanta Pharmaceuticals, IncCompleted
-
Owlstone LtdClinical Research and Trials Unit (Norfolk & Norwich University Hospital,... and other collaboratorsNot yet recruiting
-
GlaxoSmithKlineTerminatedLiver Diseases | HIV Infection | Thrombocytopenia | Hepatitis C Virus | HBV | NASH - Nonalcoholic Steatohepatitis | Human Immunodeficiency Virus | Chronic Liver Disease | HCV | Non-alcoholic Steatohepatitis | Hepatitis B VirusUnited States, Spain, Taiwan, Italy, Belgium, France, Korea, Republic of, Canada, Russian Federation, Pakistan, Poland, India, Argentina
-
Stanford UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingObesity | Diabetes Mellitus, Type 2 | Insulin Resistance | PreDiabetes | Diet Modification | Nonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
Enanta Pharmaceuticals, IncCompletedNASHUnited States, Czechia, Slovakia
-
Sonic IncytesActive, not recruitingLiver Fibroses | Non-Alcoholic Fatty Liver Disease (NAFLD) | Non-Alcoholic Steatohepatitis (NASH) | Liver SteatosesUnited States
-
Joslin Diabetes CenterActive, not recruitingType 1 Diabetes | Fibrosis, Liver | Nonalcoholic Steatohepatitis | Cirrhosis, Liver | Nonalcoholic Fatty LiverUnited States
-
Astellas Pharma IncCompletedNon-Alcoholic SteatohepatitisUnited Kingdom, Belgium, Switzerland, Germany, France, Romania, Czech Republic
-
OSF Healthcare SystemCompletedHepatic Encephalopathy | Hepatitis C | Cirrhosis | Nonalcoholic SteatohepatitisUnited States
-
Medical College of WisconsinWithdrawnNon-Alcoholic SteatohepatitisUnited States
-
Mirum Pharmaceuticals, Inc.CompletedNon-Alcoholic SteatohepatitisUnited States
-
University of California, San DiegoCompletedNon Alcoholic SteatohepatitisUnited States
-
Enanta Pharmaceuticals, IncICON Clinical Research; Triangle BiostatisticsCompletedNon-Alcoholic SteatohepatitisUnited States, United Kingdom, New Zealand, Canada, France, Puerto Rico
-
Stanford UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingNon Alcoholic SteatohepatitisUnited States
-
University of Colorado, DenverCompletedNon-Alcoholic SteatohepatitisUnited States
-
GenfitTerminatedNon Alcoholic SteatohepatitisUnited States
-
Bristol-Myers SquibbCompletedNon-Alcoholic SteatohepatitisUnited States